1840
C. W. Liskey, J. F. Hartwig
PAPER
used as received. Flash column chromatography was performed on
Silicycle Siala-P silica gel or on a Teledyne Isco CombiFlash Rf au-
tomated chromatography system with 4 g RediSep Rf Gold normal-
phase silica columns. Products were visualized on TLC plates by a
254 nm UV lamp or by staining with CAM or KMnO4. GC-MS data
were obtained on an Agilent 6890-N GC system containing an
Alltech EC-1 capillary column and an Agilent 5973 mass selective
detector. NMR spectra were acquired on 400 MHz Bruker, or 600
Bruker spectrometers, at University of California, Berkeley NMR
facility, relative to a residual solvent peak [CDCl3 δ = 7.26 (1H) and
77.23 (13C)]. Mass spectroscopy analyses were performed at the
University of California, Berkeley Mass Spectroscopy Center.
J = 18.7 Hz, 3 H), 1.87 (dd, J = 13.9, 2.9 Hz, 1 H), 1.58 (t, J = 12.8
Hz, 1 H), 1.38 (s, 3 H), 1.36 (s, 3 H), 1.35 (d, J = 6.2 Hz, 3 H).
13C NMR (151 MHz, CDCl3): δ = 138.80, 133.50, 132.44, 130.89,
130.63, 71.25, 65.15, 45.96, 31.21, 28.11, 23.14, 21.05.
HRMS (EI): m/z [M]+ calcd for C13H18BClO2: 252.1088; found:
252.1092.
2-(3-Chloro-2-fluoro-5-methylphenyl)-4,4,6-trimethyl-1,3,2-di-
oxaborinane (7e)
White solid; yield: 232 mg (86%).
1H NMR (600 MHz, CDCl3): δ = 7.34 (br s, 1 H), 7.21 (br s, 1 H),
4.37 (dqd, J = 12.3, 6.2, 3.0 Hz, 1 H), 2.28 (s, 3 H), 1.88 (dd,
J = 14.0, 2.9 Hz, 1 H), 1.62 (dd, J = 13.7, 12.0 Hz, 1 H), 1.38 (s, 6
H), 1.35 (d, J = 6.2 Hz, 3 H).
Arene C–H Borylation with Bis(hexylene glycolato)diboron;
General Procedure
In an argon-filled glove box, arene (1.0 mmol), bis(hexylene glyco-
lato)diboron (254 mg, 1.0 mmol), [Ir(COD)(OMe)]2 (3.3 mg, 5.0
μmol, 0.50 mol%), dtbpy (2.7 mg, 10.0 μmol, 1.0 mol%), and THF
(1 mL) were added to a 4-mL vial with a stir bar. The mixture was
heated in a sealed vessel at 65 °C for 12 h. The red soln was allowed
to cool to r.t., and the volatile materials were evaporated under re-
duced pressure for 2 h. The crude mixture was purified by column
chromatography to give the borylarene.
13C NMR (151 MHz, CDCl3): δ = 159.88 (d, J = 250.7 Hz), 134.38
(d, J = 7.6 Hz), 133.63 (d, J = 4.5Hz), 132.72, 120.32, (d, J = 21.1
Hz), 71.66, 65.47, 45.89, 31.13, 28.09, 23.06, 20.35.
HRMS (EI): m/z [M]+ calcd for C13H17BClFO2: 270.0997; found:
270.0999.
1-[3-Bromo-5-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)phe-
nyl]propan-1-one (7f)
White solid: yield: 230 mg (67%).
IR: 1691 cm–1 (C=O).
1H NMR (600 MHz, CDCl3): δ = 8.22 (s, 1 H), 8.10 (s, 1 H), 8.07
(s, 1 H), 4.35 (dqd, J = 12.2, 6.1, 2.9 Hz, 1 H), 3.02 (q, J = 7.2 Hz,
2 H), 1.89 (dd, J = 14.0, 2.8 Hz, 1 H), 1.61 (m, 1 H), 1.39 (s, 3 H),
1.37 (s, 3 H), 1.36 (d, J = 6.2 Hz, 3 H), 1.22 (t, J = 7.2 Hz, 3 H).
13C NMR (151 MHz, CDCl3): δ = 200.04, 140.83, 137.95, 132.50,
131.65, 122.72, 71.62, 65.39, 45.95, 31.93, 31.14, 28.11, 23.06,
8.09.
2-[3,5-Bis(trifluoromethyl)phenyl]-4,4,6-trimethyl-1,3,2-dioxa-
borinane (7a)
White solid; yield: 324 mg (98%).
1H NMR (600 MHz, CDCl3): δ = 8.22 (s, 2 H), 7.88 (s, 1 H), 4.38
(dqd, J = 12.3, 6.2, 2.9 Hz, 1 H), 1.92 (dd, J = 14.0, 2.9 Hz, 1 H),
1.62 (m, 1 H), 1.41 (s, 3 H), 1.39 (s, 3 H), 1.38 (d, J = 6.2 Hz, 3 H).
13C NMR (151 MHz, CDCl3): δ = 133.70, 130.50, 130.28, 124.61,
123.75, 122.80, 71.86, 65.56, 45.95, 31.06, 28.07, 22.99.
HRMS (EI): m/z [M]+ calcd for C14H15BF6O2: 340.1069; found:
340.1069.
HRMS (EI): m/z [M]+ calcd for C15H20BBrO3: 338.0689; found:
338.0691.
2-(3,5-Dimethylphenyl)-4,4,6-trimethyl-1,3,2-dioxaborinane
(7b)
3-Chloro-5-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)phenyl
Pivalate (7g)
White solid; yield: 325 mg (96%).
IR: 1756 cm–1 (C=O).
1H NMR (600 MHz, CDCl3): δ = 7.62 (d, J = 1.0 Hz, 1 H), 7.32 (t,
J = 7.2 Hz, 1 H), 7.10 (t, J = 1.9 Hz, 1 H), 4.33 (dqd, J = 12.1, 6.1,
2.9 Hz, 1 H), 1.87 (dd, J = 14.0, 2.8 Hz, 1 H), 1.62–1.52 (m, 1 H),
1.37 (s, 3 H), 1.35 (d, J = 2.6 Hz, 12 H), 1.34 (d, J = 6.3 Hz, 3 H).
13C NMR (151 MHz, CDCl3): δ = 176.79, 151.05, 133.90, 130.96,
124.62, 123.80, 71.47, 65.28, 45.95, 39.04, 31.55, 31.13, 28.09,
27.10, 23.06, 22.62.
White solid; yield: 116 mg (50%).
1H NMR (600 MHz, CDCl3): δ = 7.44 (s, 2 H), 7.05 (s, 1 H), 4.35
(dqd, J = 12.3, 6.2, 3.0 Hz, 1 H), 2.33 (s, 6 H), 1.87 (dd, J = 13.9,
2.9 Hz, 1 H), 1.59 (m, 1 H), 1.39 (s, 3 H), 1.37 (s, 3 H), 1.36 (d,
J = 6.2 Hz, 3 H).
13C NMR (151 MHz, CDCl3): δ = 136.69, 132.01, 131.38, 70.87,
64.92, 46.06, 31.30, 28.13, 23.25, 21.25.
HRMS (EI): m/z [M]+ calcd for C14H21BO2: 232.1635; found:
232.1636.
2-(3,5-Dimethoxyphenyl)-4,4,6-trimethyl-1,3,2-dioxaborinane
HRMS (EI): m/z [M]+ calcd for C17H24BClO4: 338.1456; found:
338.1459.
(7c)
White solid; yield: 164 mg (62%).
1H NMR (600 MHz, CDCl3): δ = 6.97 (d, J = 2.4 Hz, 2 H), 6.52 (t,
J = 2.4 Hz, 1 H), 4.34 (dqd, J = 12.3, 6.2, 2.9 Hz, 1 H), 3.82 (s, 6 H),
1.86 (dd, J = 13.9, 2.9 Hz, 1 H), 1.58 (m, 1 H), 1.37 (s, 3 H), 1.36
(s, 3 H), 1.34 (d, J = 6.2 Hz, 3 H).
13C NMR (151 MHz, CDCl3): δ = 160.23, 110.90, 103.14, 71.06,
65.05, 55.28, 45.98, 31.23, 28.12, 23.17.
N,N-Diethyl-3-methyl-5-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-
yl)benzamide (7h)
Colorless oil; yield: 203 mg (64%).
IR: 1635 cm–1 (C=O).
1H NMR (600 MHz, CDCl3): δ = 7.62 (s, 1 H), 7.60 (s, 1 H), 7.21
(s, 1 H), 4.33 (ddd, J = 11.5, 6.1, 2.9 Hz, 1 H), 3.53 (s, 2 H), 3.24 (s,
2 H), 2.36 (d, J = 5.0 Hz, 3 H), 1.90–1.81 (m, 1 H), 1.62–1.52 (m, 1
H), 1.36 (s, 3 H), 1.35 (d, J = 5.0 Hz, 3 H), 1.33 (d, J = 6.2 Hz, 3 H),
1.25 (d, J = 6.2 Hz, 3 H), 1.10 (s, 3 H).
13C NMR (151 MHz, CDCl3): δ = 171.96, 136.91, 136.29, 135.02,
128.84, 128.68, 71.06, 65.02, 45.99, 43.25, 39.07, 31.23, 28.12,
23.16, 21.26, 14.12, 12.90.
HRMS (EI): m/z [M]+ calcd for C14H21BO4: 264.1533; found:
264.1540.
2-(3-Chloro-5-methylphenyl)-4,4,6-trimethyl-1,3,2-dioxabori-
nane (7d)
White solid; yield: 216 mg (86%).
1H NMR (600 MHz, CDCl3): δ = 7.57 (s, 1 H), 7.48 (s, 1 H), 7.18
(d, J = 12.2 Hz, 1 H), 4.34 (dqd, J = 12.3, 6.2, 2.9 Hz, 1 H), 2.32 (d,
HRMS (EI): m/z [M + H]+ calcd for C18H29BNO3: 318.2235; found:
318.2237.
Synthesis 2013, 45, 1837–1842
© Georg Thieme Verlag Stuttgart · New York